X-18588055-A-G

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong

The NM_001323289.2(CDKL5):​c.656A>G​(p.Gln219Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: not found (cov: 23)

Consequence

CDKL5
NM_001323289.2 missense

Scores

10
4
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 8.94
Variant links:
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.951

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKL5NM_001323289.2 linkc.656A>G p.Gln219Arg missense_variant Exon 9 of 18 ENST00000623535.2 NP_001310218.1 O76039-2
CDKL5NM_001037343.2 linkc.656A>G p.Gln219Arg missense_variant Exon 10 of 22 NP_001032420.1 O76039-1
CDKL5NM_003159.3 linkc.656A>G p.Gln219Arg missense_variant Exon 9 of 21 NP_003150.1 O76039-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKL5ENST00000623535.2 linkc.656A>G p.Gln219Arg missense_variant Exon 9 of 18 1 NM_001323289.2 ENSP00000485244.1 O76039-2

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
Cov.:
29
GnomAD4 genome
Cov.:
23

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 2 Uncertain:1
-
3billion
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The variant is not observed in the gnomAD v2.1.1 dataset. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.70; 3Cnet: 0.99). A different missense change at the same codon (p.Gln219Pro) has been reported to be associated with CDKL5 related disorder (ClinVar ID: VCV000189549 / PMID: 23151060). However the evidence of pathogenicity is insufficient at this time. Therefore, this variant is classified as Uncertain significance according to the recommendation of ACMG/AMP guideline. -

Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Uncertain:1
Dec 24, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CDKL5 protein function. This variant has not been reported in the literature in individuals affected with CDKL5-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 219 of the CDKL5 protein (p.Gln219Arg). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.35
D
BayesDel_noAF
Pathogenic
0.26
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.20
T;T;.;T;.;.
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.91
.;D;D;D;D;D
M_CAP
Pathogenic
0.76
D
MetaRNN
Pathogenic
0.95
D;D;D;D;D;D
MetaSVM
Benign
-0.30
T
MutationAssessor
Uncertain
2.4
M;.;.;M;.;M
PrimateAI
Pathogenic
0.87
D
PROVEAN
Uncertain
-4.0
D;.;.;D;.;.
REVEL
Pathogenic
0.70
Sift
Pathogenic
0.0
D;.;.;D;.;.
Sift4G
Pathogenic
0.0010
D;.;.;D;D;D
Polyphen
1.0
D;.;.;D;.;.
Vest4
0.96
MutPred
0.81
Gain of phosphorylation at T222 (P = 0.071);Gain of phosphorylation at T222 (P = 0.071);Gain of phosphorylation at T222 (P = 0.071);Gain of phosphorylation at T222 (P = 0.071);Gain of phosphorylation at T222 (P = 0.071);Gain of phosphorylation at T222 (P = 0.071);
MVP
0.98
MPC
2.3
ClinPred
0.99
D
GERP RS
6.1
Varity_R
0.99
gMVP
0.98

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chrX-18606175; API